Allergen-Specific Immunotherapy in Patients 55 Years and Older: Results and Review of Literature

Abstract

Introduction Over the years the immune system suffers many morphologic and functional alterations, which result in a peak of function in puberty and a gradual decrease in the elderly.

Aim Treat patients 55 years or older with allergic rhinitis with immunotherapy and then analyze the response to allergens.

Materials and Methods From June 2009 to July 2010, 104 charts of patients 55 years or older with allergic complaints were evaluated. The patients were selected by anamnesis, physical examination, and otorhinolaryngologic exam. The patients had cutaneous test for mites before and after 1 year of sublingual specific immunotherapy. The cutaneous response was classified as negative (absent), light, moderate, or severe.

Results Before vaccination, 42 (40.4%) patients were classified as having a severe form of allergy and 62 (59.6%) as having a moderate allergy. After the specific therapy, 40 (38.4%) patients were classified as negative (absent), 37 (35.6%) as light, 19 (18.3%) as moderate, and 8 (7.7%) as severe responses.

Conclusion Immunotherapy, a desensitization technique, is indicated in cases which patients cannot avoid the exposure to allergens and in situations where pharmacologic therapy is not ideal. Specific immunotherapy to treat the allergic rhinitis in elderly patients was efficient and had no collateral effects, and in addition to the clinical benefit, improvement in the cutaneous test could also be observed.

Keywords

immunotherapy - aged - rhinitis

• References

• 1 Machado PP. O baú dos sonhos adormecidos: a dimensão simbólica da rinite alérgica em um estudo de caso. Bol Psicol 2007; 57 (126) 89-106
• 2 McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007; 87: 873-904
• 3 Graham JE, Christian LM, Kiecolt-Glaser JK. Stress, age, and immune function: toward a lifespan approach. J Behav Med 2006; 29: 389-400
• 4 Miller RA, Garcia G, Kirk CJ, Witkowski JM. Early activation defects in T lymphocytes from aged mice. Immunol Rev 1997; 160: 79-90
• 5 Pawelec G, Hirokawa K, Fülöp T. Altered T cell signalling in ageing. Mech Ageing Dev 2001; 122: 1613-1637
• 6 Fulop T, Larbi A, Douziech N, Levesque I, Varin A, Herbein G. Cytokine receptor signalling and aging. Mech Ageing Dev 2006; 127: 526-537
• 7 Bonagura VR, Hatam L, DeVoti J, Zeng F, Steinberg BM. Recurrent respiratory papillomatosis: altered CD8(+) T-cell subsets and T(H)1/T(H)2 cytokine imbalance. Clin Immunol 1999; 93: 302-311
• 8 Rizzo LV, Belfort Jr R. Ocular autoimmunity. In: Lahita RG, Chiorazzi N, Reeves WH, , eds. Textbook of the Autoimmune Diseases. Philadelphia, PA: Lippincott Williams & Wilkins; 2000: 515
• 9 Amadori A, Zanovello P, Cozzi E , et al. Study of some early immunological parameters in aging humans. Gerontology 1988; 34: 277-283
• 10 Ewers I, Rizzo LV, Kalil F. Imunologia e envelhecimento. Einstein 2008; 6 (Suppl. 01) S13-S20
• 11 Silva TM. Perfil das Citocinas IL4, IL5, IL8e IFN-ã Analisadas por T-PCR em Tecido de Mucosa Nasal de Pacientes Portadores de Rinite Alérgica. [Dissertação (mestrado)]. Belo Horizonte, Brazil: Universidade Federal de Minas Gerais, Faculdade de Medicina; 2007
• 12 Ibiapina Cda C, Sarinho ES, Camargos PA, Andrade CR, Cruz Filho AA. Allergic rhinitis: epidemiological aspects, diagnosis and treatment. J Bras Pneumol 2008; 34 (4) 230-240
• 13 Megid CBC, Cury PM, Cordeiro JA, Jorge RBB, Saidah R, Silva JBG. Tratamento da Rinite Alérgica: comparação da acunpuntura e corticóide nasal. Acta ORL 2006; 24 (2) 61-66
• 14 Benson M, Strannegård IL, Wennergren G, Strannegård O. Interleukin-5 and interleukin-8 in relation to eosinophils and neutrophils in nasal fluids from school children with seasonal allergic rhinitis. Pediatr Allergy Immunol 1999; 10: 178-185
• 15 Mygind N , ed. Allergic and Nonallergic Rhinitis: Clinical Aspects. Philadelphia, PA: Saunders; 1993
• 16 Bradding P, Feather IH, Wilson S , et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J Immunol 1993; 151: 3853-3865
• 17 Durham SR, Ying S, Varney VA , et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992; 148: 2390-2394
• 18 Baptistella E, Trotta F, Silva TP , et al. Revisão da literatura e estudo retrospectivo de 670 pacientes com rinite alérgica. ACTA ORL/Técnicas em Otorrinolaringologia 2009; 27: 85-88
• 19 Lopes MI, Miranda PJ, Sarinho E. Use of the skin prick test and specific immunoglobulin E for the diagnosis of cockroach allergy. J Pediatr (Rio J) 2006; 82 (3) 204-209
• 20 Rosário Filho NA, Baggio D, Suzuki MM, Thomaz PCP, Sugisawa S, Hanggi V. Ácaros na poeira domiciliar em Curitiba [Abstract]. Rev Bras Alerg Imunopatol 1992; 25: 15-25
• 21 Godinho R, Lanza M, Godinho A, Rodriques A, Assiz TML. Freqüência de positividade em teste cutâneo para aeroalérgenos. Rev Bras Otorrinolaringol (Engl Ed) 2003; 69 (6) 824-828
• 22 Associação Brasileira de Alergia e Imunopatologia e Sociedade Brasileira de Pediatria. Projeto Diretrizes. In: Imunoterapia alérgeno-específica. Projeto Diretrizes. Julho 2011
• 23 Mailing H, Weeke B. Position Paper of the European Academy of Allergy and Clinical Immunol. Position paper: immunotherapy. Allergy 1993; 48 (14, Suppl): 9-35
• 24 Solé D, , Mello Jr JF, Weckx LLM. , et al. II Consenso Brasileiro sobre Rinites. Rev Bras Alerg Imunopatol 2006; 29 (1) 29-58
• 25 Guidelines for the Use of Allergen Immunotherapy.. Canadian Society of Allergy and Clinical Immunology. Available at: http://www.csaci.ca/index.php?page=361 . Accessed May 22, 2011